Mycophenolate mofetil in combination with cyclosporine a (CSA) ± prednisolone versus CsA, methotrexate ± prednisolone for the prophylaxis of acute GvHD after allogeneic stem cell transplantation -: MMF, a new option in GvHD prophylaxis.

被引：0
|
作者：
Kiehl, MG
Linck, D
Schaefer-Eckart, K
Kroeger, M
Bronhaeuser, M
Blau, IW
Wandt, H
Jenke, A
Kienast, J
Armstrong, VW
Basara, N
Schroeder, H
Kraut, L
Fauser, AA
机构：
[1] Clin Hematol Oncol, BMT Unit, Idar Oberstein, Germany
[2] Clin Hematol Oncol, BMT Unit, Nurnberg, Germany
[3] Univ Hosp Munster, Clin Hematol Oncol, Munster, Germany
[4] Univ Hosp Dresden, Dept Hematol Oncol, Dresden, Germany
[5] Free Univ Berlin, Klinikum Benjamin Franklin, Dept Hematol Oncol, D-12200 Berlin, Germany
[6] Univ Hosp Gottingen, Dept Clin Chem, Gottingen, Germany
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2650
引用
收藏
页码：716A / 716A
页数：1
相关论文
共 50 条
  • [41] Low incidence of acute GVHD and relapse in standard risk patients undergoing allogeneic transplantation with CSA and MTX prophylaxis
    Byrne, JL
    Stainer, C
    Miflin, G
    Haynes, AP
    Russell, NH
    BONE MARROW TRANSPLANTATION, 1998, 21 : S118 - S118
  • [42] Tacrolimus, Mini-Methotrexate and Mycophenolate Mofetil Is Safe and Effective as Acute Gvhd Prophylaxis for Non-Myeloablative Unrelated Donor Allogeneic Stem Cell Transplantation.
    Hong, Sanghee
    Martin, Thomas
    Damon, Lloyd E.
    Kaplan, Lawrence
    Navarro, Willis H.
    Linker, Charles
    BLOOD, 2009, 114 (22) : 481 - 481
  • [43] Cyclosporine a and Mycophenolate Mofetil Vs Cyclosporine a and Methotrexate as Gvhd Prophylaxis in Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation from HLA-Identical Sibling Donor
    Pinana, Jose Luis, Sr.
    Valcarcel, David
    Martino, Rodrigo
    Fernandez, Francesc
    Barba, Pere
    Rovira, Montserrat
    Carreras, Enric
    Sureda, Anna
    Sierra, Jorge
    BLOOD, 2008, 112 (11) : 777 - 777
  • [44] Tacrolimus (FK-506) and mycophenolate mofetil (MMF) GVHD prophylaxis in pediatric allogeneic SCT (AlloSCT) recipients: Altered MMF pharmacokinetics (PK) associated with acute (A)GVHD.
    Bessmertny, O
    Farris, K
    van de Ven, C
    Harrison, L
    Osunkwo, I
    Wolownik, K
    Garvin, J
    George, D
    Del Toro, G
    Bradley, MB
    Skerrett, D
    Cairo, MS
    BLOOD, 2003, 102 (11) : 713A - 713A
  • [45] Comparison of cyclosporine (CSA) plus methylprednisolone (MePred) vs CSA plus methotrexate (MTX) for GvHD prophylaxis in HLA identical allogenic bone marrow transplantation (BMT)
    Zorsky, P
    Ballester, O
    Goldstein, S
    Hiemenz, J
    Janssen, W
    Fields, K
    Elfenbein, G
    BLOOD, 1995, 86 (10) : 1573 - 1573
  • [46] Mycophenolate mofetil (MMF)/tacrolimus (FK506) is an effective and safe regimen for graft versus host disease (GVHD) prophylaxis in pediatric allogeneic stem cell transplant (AlloSCT) recipients: Altered MMF pharmacokinetics (PK) and association with acute GVHD
    Osunkwo, I
    Bessmertny, O
    Harrison, L
    Garvin, J
    George, D
    Bradley, MB
    DelToro, G
    Wischhover, C
    Wolownik, K
    van de Ven, C
    Cheung, YK
    Cairo, MS
    PEDIATRIC RESEARCH, 2003, 53 (04) : 528A - 528A
  • [47] An Age-Dependent Pharmacokinetic Study of Intravenous and Oral Mycophenolate Mofetil in Combination with Tacrolimus for GVHD Prophylaxis in Pediatric Allogeneic Stem Cell Transplantation Recipients
    Bhatia, Monica
    Militano, Olga
    Jin, Zhezhen
    Figurski, Michal
    Shaw, Leslie
    Moore, Virginia
    Morris, Erin
    Tallamy, Bradford
    van deVen, Carmella
    Ayello, Janet
    Baxter-Lowe, LeeAnn
    Satwani, Prakash
    George, Diane
    Bradley, M. Brigid
    Garvin, James
    Cairo, Mitchell S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (03) : 333 - 343
  • [48] MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblings
    J L Piñana
    D Valcárcel
    F Fernández-Avilés
    R Martino
    M Rovira
    P Barba
    C Martínez
    S Brunet
    A Sureda
    E Carreras
    J Sierra
    Bone Marrow Transplantation, 2010, 45 : 1449 - 1456
  • [49] MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblings
    Pinana, J. L.
    Valcarcel, D.
    Fernandez-Aviles, F.
    Martino, R.
    Rovira, M.
    Barba, P.
    Martinez, C.
    Brunet, S.
    Sureda, A.
    Carreras, E.
    Sierra, J.
    BONE MARROW TRANSPLANTATION, 2010, 45 (09) : 1449 - 1456
  • [50] Cyclosporine A (CSA) vs. tacrolimus (TAC), in combination with mycophenolate mofetil (MMF) and steroids as primary immunosuppression after lung transplantation
    Zuckermann, A
    Reichenspurner, H
    Klepetko, W
    Meiser, B
    Birsan, T
    Treede, H
    Kupilik, N
    Wisser, W
    TRANSPLANTATION, 1999, 67 (07) : S236 - S236
12345